Area of research
Cardiology and Cardiovascular Medicine · Pulmonary and Respiratory Medicine
Research interest
Paul A. Iaizzo, PhD FHRS is a Professor is the Departments of Surgery, Integrative Biology & Physiology and the Carlson School of Management, at the University of Minnesota. He serves on the graduate faculties in Biomedical Engineering, Neuroscience, Integrative Biology & Physiology, Biological Science, Bioinformatics and Computational Biology and Mechanical Engineering. He is the Director of the Malignant Hyperthermia Diagnostic Center and Medtronic Professor of Visible Heart® Research, and the Associate Director and Medtronic Chair of the Institute for Engineering in Medicine.
The Last Decade in Tricuspid Regurgitation
Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance
Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY
Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse: Prevalence, Predictors, and Association With Outcomes
Prognostic Implications of Functional Tricuspid Regurgitation in Asymptomatic Degenerative Mitral Regurgitation
Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment
Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair
Mitral Annular Disjunction in the Context of Mitral Valve Prolapse
Prognostic Implications of Right Ventricular Dysfunction in Severe Degenerative Mitral Regurgitation
Indexing left ventricular end‐systolic dimension to body size: Association with mortality in patients with degenerative mitral regurgitation
Degenerative Mitral Regurgitation Outcomes in Asian Compared With European-American Institutions
Survival loss linked to guideline-based indications for degenerative mitral regurgitation surgery
Reappraisal of the Concept and Implications of Pulmonary Hypertension in Degenerative Mitral Regurgitation
Resumen: Consenso internacional para la nomenclatura y clasificación de la válvula aórtica bicúspide congénita y su aortopatía, con fines clínicos, quirúrgicos, intervencionistas y de investigación
TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation
Factors influencing post-surgical survival in degenerative mitral regurgitation
Response by Essayagh et al to Letter Regarding Article, “The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum”
Prognostic Implications of Right Ventricular Dysfunction in Degenerative Mitral Regurgitation
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society
Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse
Research Opportunities in the Treatment of Mitral Valve Prolapse
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum
New Guideline-Directed Treatments for Heart Failure
The MIDA quantitative international registry: prognostic implications of moderately elevated pulmonary artery pressure
Global epidemiology of valvular heart disease
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes
Association of transcatheter edge-to-edge repair with improved survival in older patients with severe, symptomatic degenerative mitral regurgitation
International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes